Cargando…
Identification of potential biomarkers in Barrett’s esophagus derived esophageal adenocarcinoma
Almost 50% of esophageal adenocarcinoma (EAC) patients progressed from Barrett’s esophagus (BE). EAC is often diagnosed at late stages and is related to dismal prognosis. However, there are still no effective methods for stratification and therapy in BE and EAC. Two public datasets (GSE26886 and GSE...
Autores principales: | Yi, Nan, Zhao, Hailiang, He, Juan, Xie, Xike, Liang, Liexin, Zuo, Guowen, Xiong, Mingyue, Liang, Yunxiao, Yi, Tingzhuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910260/ https://www.ncbi.nlm.nih.gov/pubmed/36759514 http://dx.doi.org/10.1038/s41598-022-17107-0 |
Ejemplares similares
-
Chemoprevention in Barrett’s esophagus and esophageal
adenocarcinoma
por: Alkhayyat, Motasem, et al.
Publicado: (2021) -
Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett’s esophagus
por: Lv, Jing, et al.
Publicado: (2019) -
Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma
por: Lv, Jing, et al.
Publicado: (2019) -
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma
por: Lopetuso, Loris Riccardo, et al.
Publicado: (2020) -
Progression of Barrett’s esophagus toward esophageal adenocarcinoma: an overview
por: Schoofs, Nele, et al.
Publicado: (2017)